SB Financial Group Inc
F:9KH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
SB Financial Group Inc
F:9KH
|
US |
|
P
|
Protagonist Therapeutics Inc
XBER:PGF
|
US |
|
Y
|
Ypsomed Holding AG
XMUN:OWX
|
CH |
|
AJ Bell PLC
F:3FY
|
UK |
|
T
|
Takashimaya Co Ltd
SWB:TKM
|
JP |
Wall St Price Targets
9KH Price Targets Summary
SB Financial Group Inc
According to Wall Street analysts, the average 1-year price target for
9KH is 18.59 EUR with a low forecast of 18.41 EUR and a high forecast of 19.14 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9KH's stock price target?
Price Target
18.59
EUR
According to Wall Street analysts, the average 1-year price target for
9KH is 18.59 EUR with a low forecast of 18.41 EUR and a high forecast of 19.14 EUR.
What is the Net Income forecast for SB Financial Group Inc?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Net Income has been 16%. The projected CAGR for the next 2 years is 9%.